TCM
MOLN

Tang Capital Management’s Molecular Partners MOLN Stock Holding History

Tang Capital Management’s Portfolio MOLN Stock Details MOLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,500
Closed -$18.1K – 161
2024
Q2 		$18.1K Sell
2,500
-97,500
-98% -$456K ﹤0.01% 127
2024
Q1 		$420K Hold
100,000
– – 0.04% 95
2023
Q4 		$418K Hold
100,000
– – 0.04% 115
2023
Q3 		$414K Buy
100,000
+60,247
+152% +$342K 0.06% 99
2023
Q2 		$247K Buy
39,753
+1,500
+4% +$9.74K 0.04% 96
2023
Q1 		$231K Buy
38,253
+16,253
+74% +$104K 0.03% 95
2022
Q4 		$144K Buy
22,000
+6,319
+40% +$41K 0.02% 84
2022
Q3 		$105K Buy
+15,681
New +$100K 0.01% 93

Other funds holding MOLN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Tang Capital Management's MOLN Position: Q3 2024 in Review

Tang Capital Management sold out of Molecular Partners (MOLN) in Q3 2024, closing a stake of 2,500 shares — an estimated $18.1K sold.

Tang Capital Management first reported a position in MOLN in Q3 2022 and held it in 8 quarters. The position peaked at $420K in Q1 2024. 5 funds tracked by Wall St. Rank hold MOLN as of Q3 2024.

  • Tang Capital Management reported no remaining Molecular Partners position as of Q3 2024 after selling out during the quarter.
  • Tang Capital Management sold 2,500 Molecular Partners shares in Q3 2024, an estimated $18.1K.
  • Tang Capital Management first reported a position in Molecular Partners in Q3 2022 and held it in 8 quarters.
  • Tang Capital Management's Molecular Partners position peaked at $420K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2024.

Based on Tang Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.